Liu Y, Sato T, Seharaseyon J, Szewczyk A, O'Rourke B, Marbán E
Department of Medicine, Johns Hopkins University, Baltimore, Maryland 21205, USA.
Ann N Y Acad Sci. 1999 Jun 30;874:27-37. doi: 10.1111/j.1749-6632.1999.tb09222.x.
Pharmacological evidence has implicated ATP-dependent potassium (KATP) channels in the mechanism of ischemic preconditioning; however, the effects of sarcolemmal KATP channels on excitability cannot account for the protection. KATP channels also exist in mitochondrial inner membrane. To test whether such channels play a role in cardioprotection, we simultaneously measured flavoprotein fluorescence, an index of mitochondrial redox state, and sarcolemmal KATP currents in intact rabbit ventricular myocytes. Our results show that diazoxide, a KATP channel opener, induced reversible oxidation of flavoproteins, but did not activate sarcolemmal KATP channels. This effect of diazoxide was blocked by 5-hydroxydecanoic acid (5-HD). We further verified that 5-HD is a selective blocker of the mitochondrial KATP channels. These methods have enabled us to demonstrate that the activity of mitochondrial KATP channels can be regulated by protein kinase C. In a cellular model of simulated ischemia, inclusion of diazoxide decreased the rate of cell death to about half of that in control. Such protection is inhibited by 5-HD. In conclusion, our results demonstrate that diazoxide targets mitochondrial but not sarcolemmal KATP channels, and imply that mitochondrial KATP channels may mediate preconditioning.
药理学证据表明,ATP依赖性钾(KATP)通道参与了缺血预处理机制;然而,肌膜KATP通道对兴奋性的影响并不能解释这种保护作用。KATP通道也存在于线粒体内膜。为了测试此类通道是否在心脏保护中发挥作用,我们同时测量了黄素蛋白荧光(线粒体氧化还原状态的指标)以及完整兔心室肌细胞中的肌膜KATP电流。我们的结果表明,KATP通道开放剂二氮嗪可诱导黄素蛋白发生可逆性氧化,但不会激活肌膜KATP通道。二氮嗪的这种作用被5-羟基癸酸(5-HD)阻断。我们进一步证实,5-HD是线粒体KATP通道的选择性阻断剂。这些方法使我们能够证明线粒体KATP通道的活性可受蛋白激酶C调节。在模拟缺血的细胞模型中,加入二氮嗪可使细胞死亡率降至对照组的约一半。这种保护作用被5-HD抑制。总之,我们的结果表明,二氮嗪作用于线粒体而非肌膜KATP通道,这意味着线粒体KATP通道可能介导预处理。